Page 54 - ITPS-7-1

INNOSC Theranostics and
Pharmacological Sciences Anticancer activity of cyanobacteria

agent and its preliminary evaluation in an orthotopic expression and suppresses tumor growth in glioblastoma
patient-derived xenograft (PDX) model. Invest New Drugs, xenografts. Invest New Drugs, 34: 24–40.
37: 364–374.
https://doi.org/10.1007/s10637-015-0303-x
https://doi.org/10.1007/s10637-018-0647-0
35. Mooberry SL, Leal RM, Tinley TL, et al., 2003, The molecular
25. Gunasekera SP, Owle CS, Montaser R, et al., 2011, pharmacology of symplostatin 1: A new antimitotic
Malyngamide 3 and cocosamides A and B from the marine dolastatin 10 analog. Int J Cancer, 104: 512–521.
cyanobacterium Lyngbya majuscula from Cocos Lagoon, https://doi.org/10.1002/ijc.10982
guam. J Nat Prod, 74: 871–876.
36. MacMillan JB, Molinski TF, 2002, Caylobolide A, a unique
https://doi.org/10.1021/np1008015
36-membered macrolactone from a bahamian Lyngbya
26. Michon S, Cavelier F, Salom-Roig XJ, 2021, Synthesis and majuscula. Org Lett, 4: 1535–1538.
biological activities of cyclodepsipeptides of aurilide family https://doi.org/10.1021/ol025759p
from marine origin. Mar Drugs, 19: 55.
37. Salvador LA, Paul VJ, Luesch H, 2010, Caylobolide B, a
https://doi.org/10.3390/md19020055
macrolactone from symplostatin 1-producing marine
27. Han B, Gross H, Goeger DE, et al., 2006, Aurilides B and C, Cyanobacteria Phormidium spp. from Florida. J Nat Prod,
cancer cell toxins from a Papua new Guinea collection of 73: 1606–1609.
the marine cyanobacterium Lyngbya majuscula. J Nat Prod, https://doi.org/10.1021/np100467d
69: 572–575.
38. Tao Y, Li P, Zhang D, et al., 2018, Samholides, swinholide-
https://doi.org/10.1021/np0503911
related metabolites from a marine Cyanobacterium cf.
28. Robles-Bañuelos B, Durán-Riveroll LM, Rangel-López E, Phormidium sp. J Org Chem, 83: 3034–3046.
et al., 2022, Marine Cyanobacteria as sources of lead https://doi.org/10.1021/acs.joc.8b00028
anticancer compounds: A review of families of metabolites
with cytotoxic, antiproliferative, and antineoplastic effects. 39. Afonso TB, Costa MS, Rezende De Castro R, et al., 2016,
Molecules, 27: 4814. Bartolosides E-K from a marine coccoid cyanobacterium.
J Nat Prod, 79: 2504–2513.
https://doi.org/10.3390/molecules27154814
https://doi.org/10.1021/acs.jnatprod.6b00351
29. Yao G, Wang W, Ao L, et al., 2018, Improved total synthesis
and biological evaluation of coibamide A analogues. J Med 40. Sasaki H, Teruya T, Fukazawa H, et al., 2011, Revised structure
Chem, 61: 8808–8916. and structure-activity relationship of bisebromoamide
and structure of norbisebromoamide from the marine
https://doi.org/10.1021/acs.jmedchem.8b01141
cyanobacterium Lyngbya sp. Tetrahedron, 67: 990–994.
30. Medina RA, Goeger DE, Hills P, et al., 2008, Coibamide A, 41. Suzuki K, Mizuno R, Suenaga K, et al., 2013, Bisebromoamide,
a potent antiproliferative cyclic depsipeptide from the an extract from Lyngbya species, induces apoptosis through
panamanian marine cyanobacterium Leptolyngbya sp. J Am ERK and mTOR inhibitions in renal cancer cells. Cancer
Chem Soc, 130: 6324–6325.
Med, 2: 32–39.
https://doi.org/10.1021/ja801383f
https://doi.org/10.1002/cam4.53
31. Kazemi S, Kawaguchi S, Badr CE, et al., 2021, Targeting 42. Johnston HJ, Boys SK, Makda A, et al., 2016, Naturally
of HER/ErbB family proteins using broad spectrum inspired peptide leads: Alanine scanning reveals an
Sec61 inhibitors coibamide A and apratoxin A. Biochem actin-targeting thiazole analogue of bisebromoamide.
Pharmacol, 183: 114317.
Chembiochem, 17: 1621–1627.
https://doi.org/10.1016/j.bcp.2020.114317
https://doi.org/10.1002/cbic.201600257
32. Shi W, Lu D, Wu C, et al., 2021, Coibamide A kills cancer 43. Pereira AR, Kale AJ, Fenley AT, et al., 2012, The
cells through inhibiting autophagy. Biochem Biophys Res carmaphycins, new proteasome inhibitors exhibiting an
Commun, 547: 52–58.
α,β-epoxyketone warhead from a marine cyanobacterium.
https://doi.org/10.1016/j.bbrc.2021.01.112 Chembiochem, 13: 810–817.
33. Tranter D, Paatero AO, Kawaguchi S, et al., 2020, Coibamide https://doi.org/10.1002/cbic.201200007
A targets Sec61 to prevent biogenesis of secretory and 44. Brumley DA, Gunasekera SP, Chen QY, et al., 2020,
membrane proteins. ACS Chem Biol, 15: 2125–2136.
Discovery, total synthesis and SAR of anaenamides A and B:
https://doi.org/10.1021/acschembio.0c00325 Anticancer cyanobacterial depsipeptides with a chlorinated
pharmacophore. Org Lett, 22: 4235–4239.
34. Serrill JD, Wan X, Hau AM, et al., 2016, Coibamide A,
a natural lariat depsipeptide, inhibits VEGFA/VEGFR2 https://doi.org/10.1021/acs.orglett.0c01281

Volume 7 Issue 1 (2024) 11 https://doi.org/10.36922/itps.1388